PortfoliosLab logoPortfoliosLab logo
AKO-A vs. ELV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AKO-A vs. ELV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Embotelladora Andina S.A (AKO-A) and Elevance Health Inc (ELV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AKO-A achieves a -10.20% return, which is significantly lower than ELV's 20.02% return. Over the past 10 years, AKO-A has underperformed ELV with an annualized return of 8.38%, while ELV has yielded a comparatively higher 13.78% annualized return.


AKO-A

1D
-11.01%
1M
-7.42%
YTD
-10.20%
6M
-8.49%
1Y
4.96%
3Y*
25.94%
5Y*
21.94%
10Y*
8.38%

ELV

1D
0.63%
1M
10.60%
YTD
20.02%
6M
27.26%
1Y
8.57%
3Y*
-2.38%
5Y*
3.00%
10Y*
13.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AKO-A vs. ELV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AKO-A
Embotelladora Andina S.A
-10.20%69.94%22.39%32.28%25.25%-15.56%-9.03%-14.12%-25.96%33.08%
ELV
Elevance Health Inc
20.02%-3.14%-20.72%-6.89%11.83%46.12%7.74%16.33%18.11%58.72%

Correlation

The correlation between AKO-A and ELV is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

-0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.02

Correlation (10Y)
Calculated over the trailing 10-year period

0.06

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2001

0.08

Fundamentals

Market Cap

AKO-A:

$3.06B

ELV:

$92.16B

EPS

AKO-A:

$1.95K

ELV:

$23.46

PE Ratio

AKO-A:

0.01

ELV:

17.82

PS Ratio

AKO-A:

0.00

ELV:

0.47

PB Ratio

AKO-A:

0.00

ELV:

2.10

Total Revenue (TTM)

AKO-A:

$3.42T

ELV:

$200.42B

Gross Profit (TTM)

AKO-A:

$1.34T

ELV:

$46.43B

EBITDA (TTM)

AKO-A:

$620.88B

ELV:

$8.92B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AKO-A vs. ELV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AKO-A
AKO-A Risk / Return Rank: 4747
Overall Rank
AKO-A Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
AKO-A Sortino Ratio Rank: 4444
Sortino Ratio Rank
AKO-A Omega Ratio Rank: 4646
Omega Ratio Rank
AKO-A Calmar Ratio Rank: 4848
Calmar Ratio Rank
AKO-A Martin Ratio Rank: 4949
Martin Ratio Rank

ELV
ELV Risk / Return Rank: 4747
Overall Rank
ELV Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
ELV Sortino Ratio Rank: 4444
Sortino Ratio Rank
ELV Omega Ratio Rank: 4646
Omega Ratio Rank
ELV Calmar Ratio Rank: 4949
Calmar Ratio Rank
ELV Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AKO-A vs. ELV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Embotelladora Andina S.A (AKO-A) and Elevance Health Inc (ELV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AKO-AELVDifference
Sharpe ratioReturn per unit of total volatility

-0.13

Sortino ratioReturn per unit of downside risk

0.00

Omega ratioGain probability vs. loss probability

1.08

1.08

0.00

Calmar ratioReturn relative to maximum drawdown

0.22

0.28

-0.06

Martin ratioReturn relative to average drawdown

0.55

0.51

+0.04

AKO-A vs. ELV - Sharpe Ratio Comparison

The current AKO-A Sharpe Ratio is 0.10, which is lower than the ELV Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of AKO-A and ELV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AKO-AELVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.10

0.22

-0.13

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.52

0.10

+0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.20

0.45

-0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

0.20

0.46

-0.26

Drawdowns

AKO-A vs. ELV - Drawdown Comparison

The maximum AKO-A drawdown since its inception was -79.18%, which is greater than ELV's maximum drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for AKO-A and ELV.


Loading charts...

Drawdown Indicators


AKO-AELVDifference

Max Drawdown

Largest peak-to-trough decline

-79.18%

-67.19%

-11.99%

Max Drawdown (1Y)

Largest decline over 1 year

-22.40%

-30.60%

+8.20%

Max Drawdown (3Y)

Largest decline over 3 years

-25.41%

-50.38%

+24.97%

Max Drawdown (5Y)

Largest decline over 5 years

-25.41%

-50.38%

+24.97%

Max Drawdown (10Y)

Largest decline over 10 years

-63.51%

-50.38%

-13.13%

Current Drawdown

Current decline from peak

-22.40%

-23.19%

+0.79%

Average Drawdown

Average peak-to-trough decline

-30.92%

-15.29%

-15.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.07%

16.76%

-7.69%

Volatility

AKO-A vs. ELV - Volatility Comparison

Embotelladora Andina S.A (AKO-A) has a higher volatility of 16.27% compared to Elevance Health Inc (ELV) at 8.30%. This indicates that AKO-A's price experiences larger fluctuations and is considered to be riskier than ELV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AKO-AELVDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.27%

8.30%

+7.97%

Volatility (6M)

Calculated over the trailing 6-month period

41.68%

27.26%

+14.42%

Volatility (1Y)

Calculated over the trailing 1-year period

52.00%

38.59%

+13.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.35%

28.93%

+13.42%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.97%

30.84%

+11.13%

Dividends

AKO-A vs. ELV - Dividend Comparison

AKO-A's dividend yield for the trailing twelve months is around 5.09%, more than ELV's 1.64% yield.


PositionTTM20252024202320222021202020192018201720162015
AKO-A
Embotelladora Andina S.A
5.09%5.24%6.95%9.27%17.81%8.12%5.74%4.72%4.16%2.63%2.34%2.50%
ELV
Elevance Health Inc
1.64%1.95%1.77%1.26%1.00%0.98%1.18%1.06%1.14%1.20%1.81%1.79%

Financials

AKO-A vs. ELV - Financials Comparison

This section allows you to compare key financial metrics between Embotelladora Andina S.A and Elevance Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00B400.00B600.00B800.00B1.00T20222023202420252026
958.49B
50.18B
(AKO-A) Total Revenue
(ELV) Total Revenue
Values in USD except per share items

AKO-A vs. ELV - Profitability Comparison

The chart below illustrates the profitability comparison between Embotelladora Andina S.A and Elevance Health Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%25.0%30.0%35.0%40.0%20222023202420252026
41.0%
18.1%
Portfolio components
AKO-A - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Embotelladora Andina S.A reported a gross profit of 393.07B and revenue of 958.49B. Therefore, the gross margin over that period was 41.0%.

ELV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a gross profit of 9.10B and revenue of 50.18B. Therefore, the gross margin over that period was 18.1%.

AKO-A - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Embotelladora Andina S.A reported an operating income of 147.46B and revenue of 958.49B, resulting in an operating margin of 15.4%.

ELV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported an operating income of 2.66B and revenue of 50.18B, resulting in an operating margin of 5.3%.

AKO-A - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Embotelladora Andina S.A reported a net income of 102.93B and revenue of 958.49B, resulting in a net margin of 10.7%.

ELV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a net income of 1.76B and revenue of 50.18B, resulting in a net margin of 3.5%.


Frequently Asked Questions


AKO-A and ELV have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AKO-A has higher volatility (16.27%) compared to ELV (8.30%). In terms of maximum drawdown, AKO-A dropped -79.18% vs ELV's -67.19%.

ELV currently has the higher Sharpe Ratio (0.22 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AKO-A and ELV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer